Page 20 - BH-2-2
P. 20
Brain & Heart Oxidative stress and neurological disorders
43. Sun Y, Ge X, Li X, et al. High-fat diet promotes renal injury 53. Song T, Song X, Zhu C, et al. Mitochondrial dysfunction,
by inducing oxidative stress and mitochondrial dysfunction. oxidative stress, neuroinflammation, and metabolic
Cell Death Dis. 2020;11(10):914. alterations in the progression of Alzheimer’s disease:
A meta-analysis of in vivo magnetic resonance spectroscopy
doi: 10.1038/s41419-020-03122-4
studies. Ageing Res Rev. 2021;72:101503.
44. Pestel J, Blangero F, Watson J, Pirola L, Eljaafari A.
Adipokines in obesity and metabolic-related-diseases. doi: 10.1016/j.arr.2021.101503
Biochimie. 2023;212:48-59. 54. Nguyen A, Mandavalli A, Diaz MJ, et al. Neurosurgical
anesthesia: Optimizing outcomes with agent selection.
doi: 10.1016/j.biochi.2023.04.008
Biomedicines. 2023;11(2):372.
45. Jia G, Aroor AR, Jia C, Sowers JR. Endothelial cell senescence
in aging-related vascular dysfunction. Biochim Biophys Acta doi: 10.3390/biomedicines11020372
Mol Basis Dis. 2019;1865(7):1802-1809. 55. Bose A, Beal MF. Mitochondrial dysfunction and oxidative
stress in induced pluripotent stem cell models of Parkinson’s
doi: 10.1016/j.bbadis.2018.08.008
disease. Eur J Neurosci. 2019;49(4):525-532.
46. Miller AA, Spencer SJ. Obesity and neuroinflammation:
A pathway to cognitive impairment. Brain Behav Immun. doi: 10.1111/ejn.14264
2014;42:10-21. 56. Jurcau A. Insights into the pathogenesis of neurodegenerative
diseases: Focus on mitochondrial dysfunction and oxidative
doi: 10.1016/j.bbi.2014.04.001
stress. Int J Mol Sci. 2021;22(21):11847.
47. Han YP, Tang X, Han M, et al. Relationship between obesity
and structural brain abnormality: Accumulated evidence doi: 10.3390/ijms222111847
from observational studies. Ageing Res Rev. 2021;71:101445. 57. Espay AJ, Aybek S, Carson A, et al. Current concepts
in diagnosis and treatment of functional neurological
doi: 10.1016/j.arr.2021.101445
disorders. JAMA Neurol. 2018;75(9):1132-1141.
48. Tan BL, Norhaizan ME, Liew WP. Nutrients and
oxidative stress: Friend or foe? Oxid Med Cell Longev. doi: 10.1001/jamaneurol.2018.1264
2018;2018:9719584. 58. Makkar R, Behl T, Bungau S, et al. Nutraceuticals in
neurological disorders. Int J Mol Sci. 2020;21(12):4424.
doi: 10.1155/2018/9719584
doi: 10.3390/ijms21124424
49. Dikalov S, Itani H, Richmond B, et al. Tobacco smoking
induces cardiovascular mitochondrial oxidative stress, 59. Kang WY, Wang L, Qiu M, et al. Adrenal cavernous
promotes endothelial dysfunction, and enhances hemangioma: A case report and literature review. Beijing Da
hypertension [published correction appears in Am J Physiol Xue Xue Bao Yi Xue Ban. 2021;53(4):808-810.
Heart Circ Physiol. 2019;316(4):H939]. Am J Physiol Heart doi: 10.19723/j.issn.1671-167X.2021.04.032
Circ Physiol. 2019;316(3):H639-H646.
60. Jurca CM, Kozma K, Petchesi CD, et al. Tuberous sclerosis,
doi: 10.1152/ajpheart.00595.2018
type II diabetes mellitus and the PI3K/AKT/mTOR signaling
50. Caliri AW, Tommasi S, Besaratinia A. Relationships among pathways-case report and literature review. Genes (Basel).
smoking, oxidative stress, inflammation, macromolecular 2023;14(2):433.
damage, and cancer. Mutat Res Rev Mutat Res. doi: 10.3390/genes14020433
2021;787:108365.
61. Karageorgiou I, Chandler C, Whyte MB. Silent diabetes
doi: 10.1016/j.mrrev.2021.108365
mellitus, periodontitis and a new case of thalamic abscess.
51. Durazzo TC, Mattsson N, Weiner MW, Alzheimer’s BMJ Case Rep. 2014;2014:bcr2014204654.
Disease Neuroimaging Initiative. Smoking and increased doi: 10.1136/bcr-2014-204654
Alzheimer’s disease risk: A review of potential mechanisms.
Alzheimers Dement. 2014;10(3 Suppl):S122-S145. 62. Cahyanur R, Setyawan W, Sudrajat DG, Setyowati S,
Purnamasari D, Soewondo P. Diagnosis and management
doi: 10.1016/j.jalz.2014.04.009
of acromegaly: Giant invasive adenoma. Acta Med Indones.
52. Hahad O, Lelieveld J, Birklein F, Lieb K, Daiber A, 2011;43(2):122-128.
Münzel T. Ambient air pollution increases the risk of 63. Ridker PM, MacFadyen JG, Thuren T, et al. Effect of
cerebrovascular and neuropsychiatric disorders through interleukin-1β inhibition with canakinumab on incident
induction of inflammation and oxidative stress. Int J Mol Sci. lung cancer in patients with atherosclerosis: Exploratory
2020;21(12):4306.
results from a randomised, double-blind, placebo-controlled
doi: 10.3390/ijms21124306 trial. Lancet. 2017;390(10105):1833-1842.
Volume 2 Issue 2 (2024) 14 doi: 10.36922/bh.2704

